700 related articles for article (PubMed ID: 23063330)
1. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells.
Mjösberg J; Bernink J; Golebski K; Karrich JJ; Peters CP; Blom B; te Velde AA; Fokkens WJ; van Drunen CM; Spits H
Immunity; 2012 Oct; 37(4):649-59. PubMed ID: 23063330
[TBL] [Abstract][Full Text] [Related]
2. Optimal identification of human conventional and nonconventional (CRTH2
Liu S; Sirohi K; Verma M; McKay J; Michalec L; Sripada A; Danhorn T; Rollins D; Good J; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2020 Aug; 146(2):390-405. PubMed ID: 32032632
[TBL] [Abstract][Full Text] [Related]
3. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
[TBL] [Abstract][Full Text] [Related]
4. Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production.
Maggi L; Montaini G; Mazzoni A; Rossettini B; Capone M; Rossi MC; Santarlasci V; Liotta F; Rossi O; Gallo O; De Palma R; Maggi E; Cosmi L; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2017 Mar; 139(3):964-976.e4. PubMed ID: 27576126
[TBL] [Abstract][Full Text] [Related]
5. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
6. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
[TBL] [Abstract][Full Text] [Related]
7. Crocin Inhibits the Type 2 Inflammatory Response Produced by ILC2s in Eosinophilic Nasal Polyps.
Xiaodong X; Tao L; Jianmin L; Jing Z; Bing Z; Jintao D; Bachert C; Luo B
Am J Rhinol Allergy; 2023 Nov; 37(6):656-669. PubMed ID: 37424236
[TBL] [Abstract][Full Text] [Related]
8. ILC2s induce adaptive Th2-type immunity in different stages of tuberculosis through the Notch-GATA3 pathway.
Li Q; Zhang J; Ma L; Wu C; Zhao J; Guan W; Li X; Yang X; Wen F
Int Immunopharmacol; 2021 Dec; 101(Pt B):108330. PubMed ID: 34862127
[TBL] [Abstract][Full Text] [Related]
9. The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice.
Han M; Rajput C; Hong JY; Lei J; Hinde JL; Wu Q; Bentley JK; Hershenson MB
J Immunol; 2017 Aug; 199(4):1308-1318. PubMed ID: 28701507
[TBL] [Abstract][Full Text] [Related]
10. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.
Nagarkar DR; Poposki JA; Tan BK; Comeau MR; Peters AT; Hulse KE; Suh LA; Norton J; Harris KE; Grammer LC; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414
[TBL] [Abstract][Full Text] [Related]
11. IL-7 induces type 2 cytokine response in lung ILC2s and regulates GATA3 and CD25 expression.
Sheikh A; Lu J; Melese E; Seo JH; Abraham N
J Leukoc Biol; 2022 Nov; 112(5):1105-1113. PubMed ID: 35603486
[TBL] [Abstract][Full Text] [Related]
12. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
[TBL] [Abstract][Full Text] [Related]
13. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
Tojima I; Shimizu T
Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
[TBL] [Abstract][Full Text] [Related]
14. Group 2 innate lymphoid cells in nasal polyposis.
Stevens WW; Kato A
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
[TBL] [Abstract][Full Text] [Related]
15. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
[TBL] [Abstract][Full Text] [Related]
16. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
[TBL] [Abstract][Full Text] [Related]
17. TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung.
Tei R; Iijima K; Matsumoto K; Kobayashi T; Lama J; Jacobsen EA; Kita H
J Allergy Clin Immunol; 2022 Mar; 149(3):1044-1059.e5. PubMed ID: 34428519
[TBL] [Abstract][Full Text] [Related]
18. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases.
Matsushita K; Kato Y; Akasaki S; Yoshimoto T
Allergol Int; 2015 Jul; 64(3):235-40. PubMed ID: 26117254
[TBL] [Abstract][Full Text] [Related]
19. Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches.
Dahlgren MW; Jones SW; Cautivo KM; Dubinin A; Ortiz-Carpena JF; Farhat S; Yu KS; Lee K; Wang C; Molofsky AV; Tward AD; Krummel MF; Peng T; Molofsky AB
Immunity; 2019 Mar; 50(3):707-722.e6. PubMed ID: 30824323
[TBL] [Abstract][Full Text] [Related]
20. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid.
Morita H; Kubo T; Rückert B; Ravindran A; Soyka MB; Rinaldi AO; Sugita K; Wawrzyniak M; Wawrzyniak P; Motomura K; Tamari M; Orimo K; Okada N; Arae K; Saito K; Altunbulakli C; Castro-Giner F; Tan G; Neumann A; Sudo K; O'Mahony L; Honda K; Nakae S; Saito H; Mjösberg J; Nilsson G; Matsumoto K; Akdis M; Akdis CA
J Allergy Clin Immunol; 2019 Jun; 143(6):2190-2201.e9. PubMed ID: 30682454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
